David W. Dodick

42.3k total citations · 18 hit papers
535 papers, 28.6k citations indexed

About

David W. Dodick is a scholar working on Psychiatry and Mental health, Pathology and Forensic Medicine and Physiology. According to data from OpenAlex, David W. Dodick has authored 535 papers receiving a total of 28.6k indexed citations (citations by other indexed papers that have themselves been cited), including 452 papers in Psychiatry and Mental health, 277 papers in Pathology and Forensic Medicine and 170 papers in Physiology. Recurrent topics in David W. Dodick's work include Migraine and Headache Studies (443 papers), Trigeminal Neuralgia and Treatments (232 papers) and Sympathectomy and Hyperhidrosis Treatments (151 papers). David W. Dodick is often cited by papers focused on Migraine and Headache Studies (443 papers), Trigeminal Neuralgia and Treatments (232 papers) and Sympathectomy and Hyperhidrosis Treatments (151 papers). David W. Dodick collaborates with scholars based in United States, United Kingdom and Germany. David W. Dodick's co-authors include Stephen D. Silberstein, Peter J. Goadsby, Richard B. Lipton, Todd J. Schwedt, Messoud Ashina, Sheena K. Aurora, Frank Porreca, Jessica Ailani, Joel R. Saper and Marcelo E. Bigal and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

David W. Dodick

519 papers receiving 27.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

New Appendix Criteria Open for a Broader Concept of Chronic Migraine

2006 721 citations David W. Dodick, Peter J. Goadsby et al. Cephalalgia profile →
OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double‐Blind, Randomized, Placebo‐Controlled Phases of the PREEMPT Clinical Program

2010 665 citations David W. Dodick, Stephen D. Silberstein et al. Headache The Journal of Head and Face Pain profile →
Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults

2012 617 citations Stephen D. Silberstein, David W. Dodick et al. Neurology profile →
Narrative Review: Reversible Cerebral Vasoconstriction Syndromes

2007 606 citations David W. Dodick, Todd J. Schwedt et al. profile →
A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease

1999 601 citations David W. Dodick et al. profile →
Fremanezumab for the Preventive Treatment of Chronic Migraine

2017 544 citations Stephen D. Silberstein, David W. Dodick et al. profile →
ARISE: A Phase 3 randomized trial of erenumab for episodic migraine

2018 423 citations David W. Dodick, Messoud Ashina et al. Cephalalgia profile →
Evaluation of Galcanezumab for the Prevention of Episodic Migraine

2018 408 citations David W. Dodick et al. profile →
Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine

2018 367 citations David W. Dodick, Stephen D. Silberstein et al. profile →
Migraine

2018 366 citations David W. Dodick profile →
Adherence to oral migraine-preventive medications among patients with chronic migraine

2014 323 citations David W. Dodick et al. Cephalalgia profile →
A Phase‐by‐Phase Review of Migraine Pathophysiology

2018 310 citations David W. Dodick Headache The Journal of Head and Face Pain profile →
Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial

2014 299 citations David W. Dodick, Peter J. Goadsby et al. profile →
Migraine

2022 281 citations Peter J. Goadsby, Rami Burstein et al. profile →
Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults

2018 256 citations David W. Dodick, Stephen D. Silberstein et al. Cephalalgia profile →
Ubrogepant for the Treatment of Migraine

2019 253 citations David W. Dodick, Richard B. Lipton et al. profile →
Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study

2020 194 citations David W. Dodick, Todd J. Schwedt et al. The Journal of Headache and Pain profile →
Migraine: integrated approaches to clinical management and emerging treatments

2021 179 citations Messoud Ashina, Håkan Ashina et al. profile →

Peers

Countries citing papers authored by David W. Dodick

Since Specialization

Citations

This map shows the geographic impact of David W. Dodick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David W. Dodick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David W. Dodick more than expected).

Fields of papers citing papers by David W. Dodick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David W. Dodick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David W. Dodick. The network helps show where David W. Dodick may publish in the future.

Co-authorship network of co-authors of David W. Dodick

This figure shows the co-authorship network connecting the top 25 collaborators of David W. Dodick. A scholar is included among the top collaborators of David W. Dodick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David W. Dodick. David W. Dodick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An objective neurophysiological study of subconcussion in female and male high school student athletes 2024 ·Scientific Reports ·Ryan C.N. D’Arcy, H. D. McCarthy, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Shaun D. Fickling, Thayne A. Munce, David W. Dodick, Christopher S. Ahmad, Ken Stein	0
2	Blood pressure elevation in erenumab‐treated patients with migraine: A retrospective real‐world experience 2024 ·Headache The Journal of Head and Face Pain ·(unknown), Carolyn Mead‐Harvey, Christopher Dodoo, (unknown), (unknown), (unknown), Aimen Vanood, David W. Dodick	11
3	Pharmacotherapies for Migraine and Translating Evidence From Bench to Bedside 2024 ·Mayo Clinic Proceedings ·Messoud Ashina, Jan Hoffmann, Håkan Ashina, Debbie L. Hay, (unknown), Thien Phu, Roberto De Icco, David W. Dodick	0
4	Clinical Applications of Digital Biomarkers in Multiple Sclerosis: A Systematic Literature Review (P5-6.013) 2024 ·Neurology ·Bryan Cobb, Richard J. Karpowicz, (unknown), (unknown), (unknown), David Jones, Licínio Craveiro, (unknown), (unknown), Edmond Teng, E. Ray Dorsey, Marwan N. Sabbagh, Mark Gudesblatt, Bart M. Demaerschalk, David W. Dodick	0
5	Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome 2024 ·Neurology ·Richard B. Lipton, Andrea M. Harriott, (unknown), (unknown), Jonathan Stokes, Pranav Gandhi, (unknown), (unknown), Joel M. Trugman, David W. Dodick	3
6	Unraveling the directional relationship of sleep and migraine-like pain 2024 ·Brain Communications ·(unknown), Caroline Machado Kopruszinski, (unknown), Hisakatsu Ito, Jill C. Rau, David W. Dodick, Edita Navratilova, Frank Porreca	0
7	Hemicrania Continua: An Update 2023 ·Current Pain and Headache Reports ·Haidar M. Al‐Khazali, Rune Häckert Christensen, Giorgio Lambru, David W. Dodick, Håkan Ashina	2
8	Long‐term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysis 2023 ·Headache The Journal of Head and Face Pain ·Stewart J. Tepper, Richard B. Lipton, Stephen D. Silberstein, David Kudrow, Messoud Ashina, Uwe Reuter, David W. Dodick, Andrea Wang, Sunfa Cheng, Jan Klatt, Daniel D. Mikol	5
9	Hypersensitivity to PACAP-38 in post-traumatic headache: a randomized clinical trial 2023 ·Brain ·Haidar M. Al‐Khazali, Rune Häckert Christensen, David W. Dodick, Basit Ali Chaudhry, Faisal Mohammad Amin, Rami Burstein, Håkan Ashina	14
10	Hypersensitivity to opening of ATP-sensitive potassium channels in post-traumatic headache 2023 ·Cephalalgia ·Haidar M. Al‐Khazali, (unknown), David W. Dodick, Basit Ali Chaudhry, Rami Burstein, Håkan Ashina	9
11	Preclinical assessment of onabotulinumtoxinA for the treatment of mild traumatic brain injury-related acute and persistent post-traumatic headache 2022 ·Cephalalgia ·Edita Navratilova, Janice Oyarzo, Trent Anderson, Ron S. Broide, Sudhakar Subramaniam, (unknown), Mitchell F. Brin, Todd J. Schwedt, David W. Dodick, Frank Porreca	7
12	A prolactin-dependent sexually dimorphic mechanism of migraine chronification 2021 ·Cephalalgia ·Daigo Ikegami, Edita Navratilova, (unknown), Aubin Moutal, Caroline Machado Kopruszinski, Rajesh Khanna, Amol Patwardhan, David W. Dodick, Frank Porreca	30
13	Reduction in migraine pain intensity in patients treated with erenumab: A post hoc analysis of two pivotal randomized studies 2021 ·Cephalalgia ·Richard B. Lipton, David W. Dodick, David Kudrow, Uwe Reuter, Nadia Tenenbaum, Feng Zhang, Gabriel Paiva da Silva Lima, Denise E. Chou, Daniel D. Mikol	4
14	Mild traumatic brain injury affects the features of migraine 2021 ·The Journal of Headache and Pain ·Ryotaro Ishii, Todd J. Schwedt, (unknown), Gina Dumkrieger, Melissa Cortez, K. C. Brennan, Kathleen B. Digre, David W. Dodick	17
15	CGRP monoclonal antibody prevents the loss of diffuse noxious inhibitory controls (DNIC) in a mouse model of post-traumatic headache 2021 ·Cephalalgia ·Caroline Machado Kopruszinski, (unknown), (unknown), (unknown), Todd J. Schwedt, David W. Dodick, Trent Anderson, Edita Navratilova, Frank Porreca	27
16	The emerging role of gammaCore® in the management of cluster headache: expert panel recommendations. 2017 ·PubMed ·Stephen D. Silberstein, Anne H. Calhoun, (unknown), David W. Dodick, Alan M. Rapoport, (unknown), (unknown), (unknown), Stewart J. Tepper	4
17	Late-life migraine accompaniments: A narrative review 2014 ·Cephalalgia ·(unknown), (unknown), Stephen D. Silberstein, David W. Dodick	44
18	BMS-927711 for the acute treatment of migraine: A double-blind, randomized, placebo controlled, dose-ranging trial 2013 ·Cephalalgia ·Ronald N. Marcus, Peter J. Goadsby, David W. Dodick, David Stock, George Manos, Tanya Fischer	225
19	Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: Results from a randomized, multicenter, double-blinded, controlled study 2012 ·Cephalalgia ·Stephen D. Silberstein, David W. Dodick, Joel R. Saper, Billy Huh, Konstantin V. Slavin, Ashwini Sharan, K. L. Reed, Samer Narouze, Alon Y. Mogilner, Jerome Goldstein, Terrence L. Trentman, Julien Vaisman, (unknown), Christian Weber, Timothy R. Deer, Robert M. Levy, (unknown), Stephanie N. Washburn, Nagy Mekhail	199
20	Acute treatment and prevention of menstrually related migraine headache 2008 ·Neurology ·Tamara Pringsheim, William Jeptha Davenport, David W. Dodick	76

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact